Skip to main content
. 2021 Sep 13;15:17534666211042529. doi: 10.1177/17534666211042529

Figure 5.

Figure 5.

Mortality in IPF patients subdivided according to the carriage of DSP rs2076295*G allele treated with (a) nintedanib and (b) pirfenidone and comparison between nintedanib and pirfenidone treatments for (c) *G allele carriers and (d) TT genotypes.